 |
|
|
|
|
|||||
|
|||||||||
|
|||||||||
 |
 |
||||||||
|
|
|||||||||
 |
|||||||||
 |
|||||||||
Donald R. Howard, M.D., Ph.D. |
Undergraduate Education: A.B. Philosophy (Boston University, Boston, MA) Medical School: Albany Medical College (Albany, NY) Graduate Ph.D.: Experimental Pathology (Immunology) (University of British Columbia, Vancouver, B.C.) Residency(s): Pathology (University of Vermont College of Medicine, Burlington, VT) Pathology (University of Southern California, Los Angeles, CA) Pathology (University of California, San Francisco, CA) Internal Medicine (University of Southern California, Los Angeles, CA) Fellowship(s): Terry Fox Fellowship (National Cancer Institute of Canada) Board Certification(s): Anatomic Pathology Clinical Pathology Additional Sub-Specialty Expertise: Breast Pathology Direct Immunofluorescence Fine Needle Aspiration Flow Cytometry Immunopathology Transplant Pathology (Kidney) |
Commentary/Medical Interests:
Dr. Howard gave the commencement address to the graduates of the Boston University Department of Philosophy in May 2007. View Dr. Howard is Chairman of the Board of CellNetix Pathology & Laboratories, and Clinical Associate Professor of Pathology at the University of Washington. As Chairman, he leads CellNetix' best-in-class, highly sub-specialized pathology group and laboratories, dedicated to quality and demonstrable excellence in patient care and results. Dr. Howard has authored numerous publications related to the immunobiology of malignant diseases, particularly breast cancer and lymphomas, and is a regular speaker at national pathology and laboratory conferences. Dr. Howard serves on the editorial advisory board of Washington G2 Reports. |
|||||||
|
|||||||||
|
|||||||||
